Imovane (Zopiclone)

Zopiclone acts as a positive allosteric modulator at the GABA_A receptor complex. By binding to a specific site, it enhances GABA’s inhibitory action, increasing chloride influx into neurons, which depresses central nervous system activity and promotes sleep.

The appropriate dose of Imovane is determined by the prescribing clinician based on individual factors such as age, renal function, and severity of insomnia. Dosage may be adjusted for elderly or hepatic‑impaired patients, and treatment is generally limited to a short duration.

Safety of zopiclone during pregnancy or lactation has not been definitively established. Healthcare providers usually advise avoiding its use in pregnant or nursing women unless the potential benefit outweighs the risk, and they often recommend non‑pharmacologic sleep strategies instead.

To place an order, submit an enquiry on the Imovane product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with benzodiazepine hypnotics, zopiclone belongs to the cyclopyrrolone class and generally has a shorter half‑life and a lower risk of dependence, although tolerance can still develop. It is often preferred when a non‑benzodiazepine option is desired for short‑term insomnia treatment.

Imovane tablets should be stored at ambient temperature, below 25 °C, in the original packaging to protect them from moisture and light. Keep the product out of reach of children and avoid storing in humid environments such as bathrooms.

Imovane is taken orally, usually shortly before bedtime, after ensuring a full night’s sleep opportunity of 7–8 hours. The tablet should be swallowed whole with a glass of water and not be taken with or after a large meal that could delay absorption.

Serious adverse reactions to zopiclone, though uncommon, include complex sleep behaviours such as sleepwalking or sleep‑driving, severe allergic reactions, and marked memory impairment. Patients should seek immediate medical attention if they experience unusual activities while asleep or signs of an allergic response.

Imovane is contraindicated in individuals with known hypersensitivity to zopiclone or other cyclopyrrolones, patients with severe hepatic impairment, and those with a history of substance dependence. Caution is also advised for elderly patients and those with existing respiratory depression.